Exploring Mono and Bis-gold(I)-DTC Complexes Against Cancer and Leishmania

Thaiz Cristina Soares Dos Santos1, Patrícia Salvador Tessaro1, Ana Luiza de Andrade Querino1

  • 1Laboratório de Síntese e Interações Bioinorgânicas (SibLab), Departmento de Química, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

Chemistry, an Asian Journal
|February 17, 2025
PubMed

Insights

New gold(I) complexes show potent anticancer and antileishmanial activities. These metallodrugs, particularly bis-gold(I) compounds, offer promising therapeutic potential against cancer and parasitic leishmaniasis.

Area of Science:

  • Medicinal Chemistry
  • Drug Discovery
  • Nanotechnology

Background:

  • Cancer and leishmaniasis pose significant global health challenges, driving the need for novel therapeutic agents.
  • Gold(I)-based compounds are emerging as promising candidates for chemotherapy, necessitating the development of analogs with improved efficacy.
  • Dithiocarbamate ligands and triphenylphosphine are utilized in the design of novel gold(I) complexes.

Purpose of the Study:

  • To synthesize and characterize five new gold(I) complexes with potential biological applications.
  • To evaluate the antiproliferative activity of these complexes against breast tumor cell lines.
  • To assess the antileishmanial efficacy of the synthesized gold(I) complexes against various Leishmania species.

Main Methods:

  • Synthesis and characterization of five novel gold(I) complexes using dithiocarbamate ligands and triphenylphosphine.
  • In vitro antiproliferative assays using human breast tumor cell lines (MDA-MB-231, 4T1) and a non-tumorigenic breast cell line (MCF-10a).
  • In vitro antileishmanial assays against intracellular amastigotes of Leishmania (Viannia) braziliensis, L. (Leishmania) amazonensis, and L. (L.) infantum.

Main Results:

  • All synthesized gold(I) complexes exhibited enhanced cytotoxic activity against breast tumor cells compared to controls.
  • The bis-gold(I) complexes demonstrated particularly potent antiproliferative effects.
  • The complexes showed significant antileishmanial activity, with bis-gold(I) compounds displaying superior efficacy against Leishmania parasites.
  • Gold complexation was crucial for the observed biological activities.

Conclusions:

  • The novel gold(I) complexes possess significant antiproliferative and antileishmanial properties.
  • Bis-gold(I) complexes represent promising lead compounds for developing new metallodrugs against cancer and leishmaniasis.
  • The findings underscore the therapeutic potential of gold-based compounds in combating major global diseases.

Related Concept Videos

Immunogold Electron Microscopy01:20

Immunogold Electron Microscopy

Immunoelectron microscopy utilizes immunogold labeling of endogenous proteins with specific antibodies to detect and localize these proteins in cells and tissues. The procedure provides insights into the distribution and quantification of protein under different stimulation conditions offering clues about their functions. Conjugating highly electron-dense gold particles with primary or secondary antibodies allow antigen detection on and within cells, with high resolution and specificity.
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...